CD38-expressing macrophages drive age-related NAD+ decline | Nature Metabolism
Macrophage Immunometabolism and Inflammaging: Roles of Mitochondrial Dysfunction, Cellular Senescence, CD38, and NAD
Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19 | Scientific Reports
Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions
Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions
Cells | Free Full-Text | Roles of CD38 in the Immune Response to Infection
M1 Macrophage Flow Cytometry Panel: R&D Systems
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Two Types of Macrophages: M1 and M2 Macrophages - Cusabio
Cells | Free Full-Text | Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages | Nature Metabolism
Metabolic Dysfunction Drives a Mechanistically Distinct Proinflammatory Phenotype in Adipose Tissue Macrophages - ScienceDirect
Frontiers | The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases
Frontiers | Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and TRPM2-dependent mechanism | Scientific Reports
CD38 in the age of COVID-19: a medical perspective | Physiological Reviews
CD38 expression in human M1 macrophages and analysis of the de novo NAD... | Download Scientific Diagram
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
THP-1 derived M1 macrophages expressed CD38 and secreted... | Download Scientific Diagram
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma | Journal for ImmunoTherapy of Cancer
Frontiers | Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma
CD38 expression in macrophages mediate "inflammaging." The senescence... | Download Scientific Diagram
Frontiers | CD38: A Significant Regulator of Macrophage Function
PTIP governs NAD+ metabolism by regulating CD38 expression to drive macrophage inflammation - ScienceDirect
